HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 296 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,969,216 | -18.7% | 88,962 | -22.7% | 1.46% | -14.0% |
| Q2 2023 | $9,796,294 | -15.9% | 115,061 | -18.2% | 1.70% | -33.0% |
| Q1 2023 | $11,646,235 | +11.9% | 140,740 | +6.3% | 2.53% | -8.6% |
| Q4 2022 | $10,411,530 | +21.5% | 132,378 | +14.3% | 2.77% | +13.7% |
| Q3 2022 | $8,572,000 | +425.9% | 115,797 | +363.2% | 2.44% | +306.2% |
| Q2 2022 | $1,630,000 | -16.1% | 25,000 | +42.9% | 0.60% | +33.0% |
| Q1 2021 | $1,943,000 | -28.0% | 17,500 | -42.0% | 0.45% | -40.7% |
| Q2 2020 | $2,700,000 | +78.8% | 30,147 | +99.0% | 0.76% | +8.7% |
| Q1 2020 | $1,510,000 | -78.2% | 15,147 | -74.9% | 0.70% | -65.0% |
| Q4 2019 | $6,923,000 | – | 60,250 | – | 2.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |